859207-02-6 Usage
Uses
Used in Medicinal Chemistry:
5-Bromo-N-(4-methoxybenzyl)pyrimidin-2-amine is used as a versatile intermediate for the synthesis of pharmaceutical compounds and bioactive agents. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Drug Discovery:
In the field of drug discovery, 5-Bromo-N-(4-methoxybenzyl)pyrimidin-2-amine is utilized as a key component in the design and synthesis of novel molecules with potential medicinal properties. Its presence in these molecules can influence their biological activity and pharmacological effects.
Used in Pharmaceutical Industry:
5-Bromo-N-(4-methoxybenzyl)pyrimidin-2-amine is used as a chemical intermediate for the preparation of various pharmaceutical compounds. Its unique structural features make it a valuable asset in the development of new drugs with improved efficacy and selectivity.
Further research and experimentation are necessary to fully explore the potential uses and properties of 5-Bromo-N-(4-methoxybenzyl)pyrimidin-2-amine, as its applications in different industries may vary based on its chemical and biological characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 859207-02-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,9,2,0 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 859207-02:
(8*8)+(7*5)+(6*9)+(5*2)+(4*0)+(3*7)+(2*0)+(1*2)=186
186 % 10 = 6
So 859207-02-6 is a valid CAS Registry Number.
859207-02-6Relevant articles and documents
Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
-
Page/Page column 12, (2009/04/24)
A compound represented by the following general formula (I) or a salt thereof, or a solvate thereof: (wherein R1, R2, R3, R4 and R5 are the same or different, and represent hydrogen atom, a halogen at
NOVEL PYRIMIDINE COMPOUNDS HAVING BENZYL (HETEROCYCLIC METHYL) AMINE STRUCTURE AND MEDICAMENT COMPRISING THE SAME
-
Page/Page column 24-25, (2009/04/24)
A compound represented by the following general formula (I), wherein R1, R2, R3, R4 and R5 represent hydrogen atom, a halogen atom, a lower alkyl group and the like, R6 represents an alkyl group, a cycloalkyl group and the like, R7 and R8 represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group and the like, R9 represents hydrogen atom, a halogen atom, a lower alkoxy group and the like, R10 and R11 represent hydrogen atom, a lower alkyl group, a lower alkoxy group, a halo(lower alkyl) group and the like, and A represents a heterocyclic ring constituted by 6 to 10 atoms, which has potent inhibitory activity on cholesterol ester transfer protein (CETP).
NOVEL PYRIMIDINE COMPOUND HAVING DIBENZYLAMINE STRUCTURE AND MEDICAMENT COMPRISING THE SAME
-
Page/Page column 21, (2009/04/24)
A compound represented by the following general formula (I), wherein R1, R2, R3, R4 and R5 represent hydrogen atom, a halo(lower alkyl) group, cyano group and the like, R6 represents an alk